Vir Das reveals his straightforward pitch to Aamir Khan for Happy Patel: “If you don’t make it, no one else will” Bollywood ...

Khatarnak Jasoos has secured its place among IMDb’s “Most Anticipated Films” of 2026, emerging as one of the year’s most ...

Vir Das reveals how Imran Khan joined Happy Patel after a surprise text message Bollywood News: Latest Bollywood News, ...

Vir Das has revealed that Imran Khan’s casting in Happy Patel: Khatarnak Jasoos began with a simple, unexpected message.

In an exclusive chat with Zoom, Vir Das, all set to amuse fans in the upcoming film Happy Patel: Khatarnak Jasoos revealed ...

Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the efficacy results hoped for in a midstage study. The investigational combo of ...

On Wednesday, Vir Biotechnology, Inc. (NASDAQ:VIR) stock traded higher after the company presented initial Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets a ...

BofA lowered the firm’s price target on Vir Biotechnology (VIR) to $13 from $14 and keeps a Buy rating on the shares. The firm is updating its ...

ALTON, Va. (WFXR) – The VIRginia International Raceway (VIR) has announced this year is its 25th anniversary and is gearing up to celebrate with high-octane heart-pumping thrills all season.

GSK is walking away from a core piece of its $345 million bet on Vir Biotechnology. The partners have ended their collaboration on anti-influenza antibodies, freeing Vir to “actively” pitch the ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the third quarter ended September 30, 2024. “This quarter was ...

- Phase 3 ECLIPSE registrational clinical program in chronic hepatitis delta on track to begin in the first half of 2025 - Tobevibart and elebsiran in chronic hepatitis delta received U.S. FDA ...